Paul McGale

Medical Statistician

Clinical Trial Service Unit

Paul is a medical statistician mainly working on case-control and cohort studies of side-effects of radiotherapy for breast cancer as well as meta-analyses of randomised trials of treatments for breast cancer. Other work has included investigations into health effects of prolonged tobacco smoking and also burden of disease caused by exposure to residential radon.

Recent publications

Neoadjuvant chemotherapy for early breast cancer - Author's reply.
Journal article

McGale P. et al, (2018), Lancet Oncol, 19
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2018), The Lancet Oncology, 19, 27 - 39
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Journal article

Pan H. et al, (2017), New England Journal of Medicine, 377, 1836 - 1846
Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomised trials
Journal article

Taylor C. et al, (2017), Journal of Clinical Oncology, 35, 1641 - 1649
Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.
Journal article

Rehammar JC. et al, (2017), Radiother Oncol

More publications